Table 8

 Performance evaluation of the Okuda, CLIP, and BCLC staging systems

Staging systemχ2 value−Log likelihoodp Value
Data are for the whole population and for PEI treatment and TACE treatment subgroups.
In the same group of patients, higher χ2 values and lower −log likelihood values were associated with better performance of the score.
CLIP, Cancer of the Liver Italian Program; BCLC, Barcelona Clinic Liver Cancer; PEI, percutaneous ethanol injection; TACE, transcatheter arterial chemoembolisation.
All patients
    Okuda50.41102.6<0.001
    CLIP76.81082.6<0.001
    BCLC89.91049.3<0.001
PEI treatment
    Okuda3.9279.90.047
    CLIP9.3275.70.002
    BCLC12.8270.70.001
TACE treatment
    Okuda22.1485.5<0.001
    CLIP10.4496.10.001
    BCLC26.2477.7<0.001